These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model. Lee A; Prideaux B; Zimmerman M; Carter C; Barat S; Angulo D; Dartois V; Perlin DS; Zhao Y Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871074 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse Model. Lee A; Wang N; Carter CL; Zimmerman M; Dartois V; Shaw KJ; Perlin DS; Zhao Y Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468476 [TBL] [Abstract][Full Text] [Related]
6. Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents. Hoehamer CF; Cummings ED; Hilliard GM; Rogers PD Antimicrob Agents Chemother; 2010 May; 54(5):1655-64. PubMed ID: 20145080 [TBL] [Abstract][Full Text] [Related]
7. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections. Cross SA; Scott LJ Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009 [TBL] [Abstract][Full Text] [Related]
8. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination. Healey KR; Nagasaki Y; Zimmerman M; Kordalewska M; Park S; Zhao Y; Perlin DS Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865 [No Abstract] [Full Text] [Related]
9. Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties. James KD; Laudeman CP; Malkar NB; Krishnan R; Polowy K Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919891 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of echinocandin antifungal drug resistance. Perlin DS Ann N Y Acad Sci; 2015 Sep; 1354(1):1-11. PubMed ID: 26190298 [TBL] [Abstract][Full Text] [Related]
12. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program. Pfaller MA; Messer SA; Rhomberg PR; Castanheira M Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853 [TBL] [Abstract][Full Text] [Related]
13. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients. Scott LJ Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856 [TBL] [Abstract][Full Text] [Related]
14. Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis. Mochizuki K; Suemori S; Udo K; Komori S; Ohkusu K; Yamada N; Ogura S J Ocul Pharmacol Ther; 2011 Oct; 27(5):531-3. PubMed ID: 21751880 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection. Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152 [No Abstract] [Full Text] [Related]
16. Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds. Maki K; Matsumoto S; Watabe E; Iguchi Y; Tomishima M; Ohki H; Yamada A; Ikeda F; Tawara S; Mutoh S Microbiol Immunol; 2008 Aug; 52(8):383-91. PubMed ID: 18667037 [TBL] [Abstract][Full Text] [Related]
17. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the Cheung YY; Hui M Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418 [TBL] [Abstract][Full Text] [Related]
18. Echinocandin use in the neonatal intensive care unit. Caudle KE; Inger AG; Butler DR; Rogers PD Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252 [TBL] [Abstract][Full Text] [Related]
19. The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans. Wiederhold NP; Najvar LK; Fothergill AW; Bocanegra R; Olivo M; McCarthy DI; Kirkpatrick WR; Fukuda Y; Mitsuyama J; Patterson TF Antimicrob Agents Chemother; 2015 Feb; 59(2):1341-3. PubMed ID: 25451054 [TBL] [Abstract][Full Text] [Related]
20. [Micafungin for therapy of invasive candidiasis in solid organ transplant recipients]. FortĂșn-Abete J Rev Iberoam Micol; 2009 Mar; 26(1):65-8. PubMed ID: 19463280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]